Transgene Biotek Ltd. - Research Center
526139 TRABI Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
0.11 |
0.14 |
0.06 |
0.09 |
- |
Operating profit |
-0.49 |
-0.24 |
-0.68 |
-0.22 |
-0.25 |
Interest |
0.03 |
0.06 |
0.09 |
0.11 |
0.11 |
Gross profit |
0.17 |
-0.22 |
-0.68 |
-0.20 |
-0.27 |
EPS (Rs) |
0.02 |
-0.03 |
-0.42 |
-0.68 |
-0.69 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
0.70 |
0.09 |
0.09 |
0.12 |
0.09 |
Stock adjustment |
- |
- |
- |
-0.07 |
- |
Raw material |
- |
- |
- |
0.02 |
0.01 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.16 |
0.16 |
0.15 |
0.16 |
0.13 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.43 |
0.23 |
0.58 |
0.20 |
0.11 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.05 |
0.05 |
2.48 |
4.98 |
4.94 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
0.13 |
-0.26 |
-3.16 |
-5.19 |
-5.21 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
75.77 |
75.77 |
75.77 |
75.77 |
75.77 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-453.95 |
-166.25 |
-1233.73 |
-254.23 |
-14591.29 |
GPM (%) |
21.46 |
-93.64 |
-478.07 |
-97.52 |
-305.41 |
NPM (%) |
15.67 |
-113.50 |
-2211.68 |
-2472.36 |
-5832.99 |